Loading...
Guest User
Welcome! Please login.
| IPO Listing At | BSE, NSE |
| IPO Issue Type | Book Build Issue |
| Issue Size | ₹318.00 Cr |
| Fresh Issue | ₹165.00 Cr |
| Offer for Sale | ₹153.00 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹338.00-340.00 per share |
| Discount | Retail: 0.00 |
| BSE Code | 543233 |
| NSE Code | CHEMCON |
| Registrar | MUFG Intime India Pvt.Ltd. |
| Lead Managers | Intensive Fiscal Services Pvt.Ltd. |
| Allotment Status | |
| DRHP |
| RHP |
| Final Prospectus |
| Anchor List |
 ₹0 A/C OpeningFree MF ₹20F&O Trade ₹0Delivery 1Cr+Customers Open Free Account → |
 ₹0 A/C Opening₹0 AMC Trading Account ₹20F&O Trade ₹20Delivery FreeIPO Apply Open Free Account → |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 44 shares and in multiples thereof
Incorporated in 1988, Chemcon Speciality Chemicals Ltd is a manufacturer of specialized chemical products i.e. HMDS and CMIC. Its product portfolio includes oilfield chemicals (Calcium Bromide, Sodium Bromide, and Zinc Bromide), Pharma intermediates, Silanes, and chemicals contract manufacturing work.
Chemcon Chemicals is a leading manufacturer of Pharmaceutical chemicals and generates maximum revenue from this particular segment. Hetero Labs Limited, Laurus Labs Ltd, Aurobindo Pharma Ltd, Lantech Pharmaceuticals Ltd, Macleods Pharma Ltd are the key customers of its Pharma chemical business. However, Shree Radha Overseas, Universal Drilling Fluids, Water Systems Speciality are some of the clients of its oilfield chemicals segment. In 2018, it was the 8th largest manufacturer of HMDS and 2nd largest manufacturer of CMIC chemical worldwide.
Company not only serves the domestic market but also export its products in overseas market such as USA, China, Japan, UAE, Serbia, Russia, Malaysia, and Azerbaijan. It has a manufacturing plant at Manjusar near Vadodara in Gujarat, 5 operational plants, 3 warehouses, and 2 leased warehouses.
Competitive strengths
• Largest manufacturer of pharmaceutical chemicals across the globe.
• Leading oilfield chemicals manufacturer in India.
• Diversified clientele base in the domestic and global markets.
• Strong and consistent financial performance.
• Dedicated manufacturing plants for each product.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Capital expenditure towards expansion of Manufacturing Facility | 41.03 |
| 2 | To meet working capital requirements | 90.00 |
| 3 | General corporate purposes | 18.76 |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Fees payable to the BRLMs (including underwriting commission) | 15.75 |
| 2 | Brokerage and selling commission payable to Syndicate Members, SCSBs, Registered Brokers, RTAs and CDPs, as applicable | 0.84 |
| 3 | Processing fees to the SCSBs and to the Sponsor Bank for ASBA Forms procured by Registered Brokers, RTAs or CDPs | 3.25 |
| 4 | Fees payable to Registrar to the Issue | 1.38 |
| 5 | Printing and distribution expenses | 1.18 |
| 6 | Advertising and marketing expenses | 2.33 |
| 7 | Listing fees, SEBI, BSE and NSE processing fees, Book-building software fees, Other regulatory expenses, Fees payable to legal counsel, and Miscellaneous | 4.58 |
Last Updated on 07-Oct-2020 06:10:00
